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 Spontaneous biophoton emission has been observed in virtually all living organisms. 
Differences between individuals of the same species have not been documented thoroughly. The 
biophoton emission of both humans and cell cultures were measured. Two humans had their 
biophoton emission repeatedly measured over the course of five months. Significant spectral 
power density peaks were able to differentiate between the two human participants, but only in the 
first month of measurement. Multiple cell cultures, some non-malignant and some cancerous, had 
their biophoton emission measured in different sizes of containers filled with nutrient agar. 
Significant spectral power density peaks were observed between the B16-BL6 and C2C12 cell 
lines. B16-BL6 cells were exposed to an extremely low-frequency electromagnetic field for one 
hour. Their biophoton emission was measured immediately following exposure. Significant 
variability was observed in the spectral power density within specific frequency ranges. These 
results indicate that there exists temporal characteristics of biophoton emission that can be used to 
successfully discriminate within and between individuals. The potential for biophoton emission to 
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 Photons are discrete quantities of light that are responsible for the transmission of the 
electromagnetic spectrum. It has been demonstrated that biological systems release photons as a 
result of their oxidative metabolism; this release is termed biophoton emission (Popp, 1994). This 
energy is typically within the order of 106 – 107 photons/m2/sec (Popp, 1979). 
 In this thesis, the observation of biophoton emission from human and cell cultures was 
investigated. Comparisons were made between human individuals as well as between a series of 
cell lines. These observations were conducted at the level of the organism, rather than focus on a 
specific area or individual cell. The impact of a novel electromagnetic field (EMF) was also 
assessed. All data was collected with the use of photomultiplier tubes (PMT). The PMTs were 
placed approximately 15cm away from the biological source for all experiments. All cell cultures 
were normalized to a size of approximately 106 cells before measurement.  
The Dual Nature of Light 
 The definitions of light, and the material that composes it, have changed multiple times 
over the course of history, from speculation to theory-based calculations to experimental data to 
theory yet again. Perhaps one of the earliest recorded theories was that of the Vaisheshika school 
of Hindu philosophy, from ~500BCE. They proposed that light was arranged into rays of tejas, or 
fire atoms, and that the various properties of the light rays were derived from the characteristics of 
the tejas; for example, their speed and arrangement. 
 Two hundred years later, the Greek mathematician Euclid proposed the law of reflection. 
This law states that when light is reflected off of a surface the incident angle is the same as the 
reflected angle. This law came with two assumptions on the characteristics of light: one, that light 
travels in a straight line; and two, that these rays of light are discrete. 
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 These ideas were expanded upon and consolidated by Arabian astronomer Ibn al-Haytham, 
considered the father of modern optics, in his 1021 book Kitab al-Manazir (Book of Optics). In 
this work, al-Haytham experimented with the laws of refraction with combinations of mirrors and 
lens. The aim of his work was to approximate the human eye. He proposed that the eye operates 
in a similar fashion to a pinhole camera, that light enters the eye rather than being emitted from it 
(a commonly accepted Greek theory), and that the image formed in the eye would be inverted. He 
deduced that the perception of vision occurs in the brain instead of the eye, and that vision is 
subjective. His work would be revived in the European Renaissance thanks to translations by 
English philosopher Robert Bacon. 
 In 1637, French philosopher René Descartes published La dioptrique, in which he proposed 
that light moved around spheres of aether (as he assumed there was no vacuum in nature) via 
instantaneous propagations. Similar theories were proposed during the rest of the 17th century, 
culminating with Dutch physicist Christiaan Huygens’ work Traité de la lumière in 1690. He 
proposed that light was analogous to sound; it travelled though a medium via waves of continuous 
frequencies. Crucially, his work also explained the reflection and refraction of waves. Descartes’ 
calculations were based on Huygens’ principle, which states that each point of a wave front acts 
as a source for additional wavelets. 
 Here we see the emergence of the two competing theories of the nature of light: particle 
and wave. In 1704, English physicist Isaac Newton completed his work, Opticks; here, he 
suggested that light behaved as a particle. He proposed that colour should be related to either the 
mass or velocity of light particles, which would explain why different colours of light were 
refracted by different amounts. 
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 The “final” triumph of particle theory came from the work of French physicist Augustin 
Fresnel, who, in the early 19th century, published both a mathematical wave theory of diffraction 
and how a wave of light could be polarized if it was a transverse wave with no longitudinal 
vibrations. The problem that still eluded physicists was the identification of the medium by which 
light travelled through, the “luminous aether”. 
 English physicist James Clerk Maxwell’s work was essential for laying the groundwork 
for our modern understanding of the properties of light. His work can be simplified into four partial 
differential equations: Gauss’ Law for electricity, Gauss’ Law for magnetism, Faraday’s Law, and 
Ampère’s Law. 
 Faraday’s Law and Ampere’s Law are incredibly important; together, they state that a 
changing magnetic field will produce a changing electric field, and that a changing electric field 
will produce a changing magnetic field. These two mechanisms can continue indefinitely, in a 
phenomenon known as propagation. From these equations, Maxwell predicted that the 
electromagnetic wave can travel without a medium due to propagation. He also accurately 
predicted the speed of this electromagnetic wave as 310 740 000m/s, which is only 0.0365% 
inaccurate from the currently accepted value of 299 792 458m/s. 
 At the dawn of the 20th century, physicists were still hunting for the “luminous aether” that 
was proposed to conduct waves of electromagnetic energy. In 1887, two American physicists, 
Albert Michelson and Edward Morley, had performed an experiment to detect this aether. They 
assumed that if light propagated through an aether perpendicular to Earth, its velocity would 
change due to interference with Earth’s velocity (Michelson & Morley, 1887). To measure this 
interference, a device later dubbed an interferometer was constructed. This device, shaped like an 
offset cross, sent a ray of light towards a set of mirrors. Here, the light was split and reflected at a 
5 
 
90° angle into the two arms. Each ray would then travel to the end of its arm, reflect off of a mirror 
located at that end, and travel back to the middle to be recombined and sent to an eyepiece.  
 If light interacted with an aether, as the light moved parallel to Earth, the “drag” produced 
by the movement of aether relative to Earth’s movement against the velocity of light would 
produce a detectable interference pattern. This phase shift was estimated to be approximately 0.4 
wavelengths; however, the highest detected phase shift was no less than 0.018 wavelengths in the 
first attempt, and after marked improvements in the efficacy of the device, the shift was no less 
than 0.02 wavelengths (Michelson & Morley, 1887). These results were a physical argument 
against the existence of a “luminous aether”. 
 But, a problem remains. Maxwell’s equations do not require that the velocity of the 
(charged) particle in question or the velocity of the observer be known in order to solve for the 
speed of the electromagnetic wave; it is a constant, c, which corresponds to the speed of light. 
Alternatively, Newtonian mechanics are based upon Galilean transformations; and these equations 
require the speed of the particle. One of these methods must be incorrect. 
 To illustrate this incompatibility, suppose that the particle is a pitcher and the wave is a 
baseball. If the pitcher is running forward at a speed v, and they throw the ball in the direction they 
are travelling, with Newtonian mechanics, the baseball travels at c + v. Maxwell would tell us that 
the speed of the ball would always be c, regardless of the speed of the pitcher. 
 At the end of the 19th century, there were still two theoretical problems that needed solving: 
what medium did light travel through? Does light follow Newtonian or Maxwellian equations? 
Work performed by the Dutch physicist Hendrik Lorentz would help solve these problems. Lorentz 
believed that light travelled though an aether. After hearing of the failure of the Michelson-Morley 
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experiments, he proposed an alternate view; the aether was fixed, and composed of charges that 
were excited by light. These charges would absorb and re-emit the light wave; mathematically, he 
was able to explain the Doppler effect, light aberration, and the results of the Fizeau experiment. 
The Fizeau experiment was similar to the Michelson-Morley experiment, but used water to show 
the interference of light rather than Earth’s velocity. 
 To move between the stationary aether and moving systems, Lorentz provided a series of 
geometrical transformations, using a term which he called “local time”. These equations would 
later be termed the Lorentz transformations, which finally united Newtonian and Maxwellian 
equations. Notably, at the time of their development, they were ad-hoc. 
 For some physicists, this was a satisfactory answer to the issue of light. For one German-
Jewish physicist, Albert Einstein, the number of ad-hoc “hoops” that was necessary for the 
justification was too many. Einstein crucially rejected the “luminous aether”, instead basing his 
work on the equations of Maxwell. His theory of special relativity, as it would later be known, was 
dependent on two postulates: 
1. The laws of electrodynamics and optics are the same in all inertial frames of reference; and 
2. The speed of light in a vacuum is constant for all observers. 
 Einstein’s (1905) paper, Zur Elektrodynamik bewegter Körper (On the Electrodynamics of 
Moving Bodies), using the above postulates, was able to mathematically describe and derive all of 
the experimental results found by previous physicists. In addition, he was able to derive the Lorentz 
transformations, meaning they were no longer an ad-hoc explanation of the unity of Newton and 
Maxwell. This work did away with a “luminous aether”; it was not needed to explain the Lorentz 
contractions or the propagation of light. 
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 Five years before Einstein’s theory of special relativity, another German physicist, Max 
Planck, would also contribute to electromagnetic theory. In 1900, Planck was able to 
mathematically describe black body radiation, with a key distinction; the energy released was 
contained in discrete packages, or quanta (Planck, 1901). Einstein would later expand on this 
concept of quanta not only for black body radiation, but for all of the electromagnetic spectrum; 
he would term this concept Lichtquant. A later term, photon, would become the preferred name in 
English. 
 The first experimenter to demonstrate Einstein’s and Planck’s quantification of light was 
American physicist Arthur Compton. His 1923 experiment using x-rays produced a scattering 
effect that did not match with classical electromagnetic theory (Thomson scattering). Compton 
was able to derive the relationship between the wavelength shift and the scattering angle that was 
observed in his experiment. This relationship would later be termed Compton scattering. 
 A key assumption Compton made for this derivation is that one X-ray photon interacted 
with one electron (Compton, 1923). This disregarded classical electromagnetic theory that 
assumed the light wave would interact with multiple electrons and produce a Doppler-like shift in 
the observed frequency. Compton scattering was one of the first concepts to be explained with 
quantum electrodynamics and is incredibly relevant in today’s medical field. 
The Photon 
 Photons are discrete packages of energy, or quanta, that possess characteristics of both 
particles and wave functions. Photons have a range of frequencies in which they operate, typically 
in the range of 102 to 1022 Hz. The amount of energy per photon is dependent on its frequency; a 
relationship that is mediated by Planck’s constant and the speed of light.  
8 
 
 Photons are traditionally thought to travel at the speed of light. This supposes that a photon 
has a rest mass of zero. Recent experiments have suggested that the rest mass of the photon is a 
non-zero value, with an upper limit of approximately 10-54 kg (Goldhaber & Nieto, 2010). The 
implication of a photon with a non-zero rest mass may allow for alternative energies based on its 
velocity and mass rather than simply based on its wavelength.  
Biophoton Emission 
Photon emission, as a method of biological communication, was first proposed by 
Russian scientist Alexander Gurswitsch in 1922 (Bischof, 2005). His experimental set-up 
consisted of onion roots, separated by either normal glass or quartz glass. He found that the 
division of cells in one root tip would stimulate division in the opposing root tip, but only when 
separated by quartz glass, not normal glass (Bischof, 2005). He concluded that there must be a 
form of “mitogenentic radiation” that could pass through the quartz in the UV range; however, 
Gurswitsch was not able to measure this proposed method of information transfer reliably 
(Bischof, 2005). The introduction of photomultiplier tubes (PMTs) provided a reliable way to 
measure photon emission from biological systems. This process is also known as ultraweak 
photon emission (UPE), due to the low intensity of the light, which cannot be observed with 
common detectors, and is not visible to the naked eye (Van Wijk, 2005).  
 All living tissue produces some form of biophoton emission. This is distinct from 
bioluminescence in that no specialized organs or metabolic pathways are required for emission 
(Cifra & Pospisil, 2014). Biophoton emission is also not a consequence of thermal radiation. 
Inanimate objects heated to a temperature range of 30 °C to 90 °C produce no increases in UPE 
(Van Wijk, 2005). At 37°C, Plank’s black-body radiation does not produce sufficient photons to 
match levels of measured biophoton emission (Cifra & Pospisil, 2014). The frequency of photons 
9 
 
emitted by biological systems are within the range of 250 – 800nm (Popp 2009). The specific 
intensities and frequencies vary for different cell types. 
 Two types of biophoton emission have been observed: spontaneous and induced. 
Spontaneous biophoton emission refers to the photons released by the organism at a normal or 
resting state, with no external influences or stimuli. Induced biophoton emission, by contrast, 
refers to the photons released by an organism after exposure to certain biotic or abiotic factors. 
These can include stress, mechanical damage, or ionizing radiation (Cifra & Pospisil, 2014). 
Induced biophoton emission is typically of greater intensity than spontaneous biophoton emission. 
 Metabolism is thought to be the common source of biophoton emission. The biophoton 
emission produced by metabolically inactive cells is very low or close to background levels. 
Metabolic pathways with oxidative reactions are proposed to be the main pathways associated with 
biophoton emission (Dotta et al., 2011). It was originally thought that biophoton emission was 
simply a consequence of metabolic activity with no meaningful effect on biological processes; 
however, recent experiments have shown that cells have the potential to “store” photons and 
release them after a certain period of time (Karbowski et al., 2016). This has led some to postulate 
that there is a biological relevance for biophoton emission, with roles in the regulation of growth 
and proliferation (Creath & Schwartz, 2005; Popp, 2009). Regardless of the biological relevance, 
biophoton emission remains a potential diagnostic tool. Takeda and colleagues were able to assess 
cancer cell populations with biophoton emission (1998).  
 Biophoton emission has also been observed in humans. Early studies were able to 
distinguish between the presence of a human from the background (Van Wijk, 2005). Human 
subjects were able to increase the amount of biophoton emission by using specific breathing 
techniques (Bischof, 2005). Edwards and colleagues systematically observed the UPE emitted 
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from the hand every 1.5h, for a total of 28h; they also observed UPE emitted from other regions, 
including, the forehead, abdomen, lower back, and chest (1989). They found the level of UPE was 
increased from the hand and forehead regions compared to the chest, abdomen, and lower back 
(Edwards et al., 1989). Popp and his colleagues were able to obtain information concerning the 
frequencies present within the UPE, significant light-right asymmetries, and the presence of a 24h 
cycle (Bischof, 2005). Longer cycles, such as a 1-4 week cycle, were also obtained from repeated 
measures of the hands and forehead (Cohen & Popp, 1997). Jung and colleagues have found 
seasonal variation in the biophoton emission from the hands (2004). 
 The estimated biophoton emission density for humans has been approximated to be 100 
photons per cm2 (Cohen & Popp, 1997). This intensity includes only photons with wavelengths 
from the visible spectrum; the potential for higher values due to infrared and ultraviolet photons is 
possible. 
 As with cells, biophoton emission from humans was also originally thought to be a by-
product of metabolism with no biological relevance. Popp (1997) and others (Creath & Schwartz, 
2005) have proposed that biophotons may act as signals for biological functions. Rahnama and 
colleagues have argued that biophotons may play a key role in neural signal propagation (2011). 
If biophoton emission has biological consequences, this may be useful in diagnostic approaches. 
The activity of various cellular-signalling pathways could be monitored via the biophoton output 
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REPEATED MEASUREMENT OF BIOPHOTON EMISSION 
FROM TWO HUMANS OVER A FIVE-MONTH PERIOD: 




 Living organisms emit photons at a low intensity level, as this emission is linked to 
metabolic processes at a cellular level. These photons are often referred to as biophotons. Human 
biophoton emission is a relatively novel field of study, with implications for the medical field. We 
repeatedly measured the biophoton emission from two male participants 138 times over a five-
month period. Photon emission was recorded using four photomultiplier tubes in a specially-
constructed dark experimental chamber. A discrimination function was able to correctly classify 
the two participants with 100% accuracy during the first month of the experiment. This 
discrimination function relied on the spectral characteristics of the photon emission, with the 0Hz 
to 3Hz frequency range as one of the key variables. Average photon counts were not a significant 
variable in the discrimination function. The ability to distinguish the two individuals was lost after 
the first month of the experiment. A possible explanation for the loss of discrimination is the 
homogenization of the experimental space. Implications for the use of human biophoton emission 





 Human biophoton emission is a relatively novel area of experimentation, with the earliest 
reported studies in the mid-1970’s. These studies were complicated by the noise produced by early 
models of photomultiplier tubes (PMTs), and had contradictory results. Two studies in 1989 and 
1990 by Edwards and colleagues, systematically observed the UPE emitted by the hand every 1.5h, 
for a total of 28h; they also observed UPE emitted from other regions, including, the forehead, 
abdomen, lower back, and chest (Van Wijk, 2005). They found the level of UPE was increased in 
the hand and forehead regions compared to the chest, abdomen, and lower back (Edwards et al., 
1989). Popp and his colleagues, notably Cohen, also conducted measurements on humans in the 
late 1990’s and early 2000’s. They were able to obtain information concerning the frequencies 
present within the UPE, significant light-right asymmetries, the presence of a 24h cycle, and a 
non-local effect (Bischof, 2005). 
 One of the main benefits of biophoton research in humans is its application as a diagnostic 
tool. The underlying mechanism to explain biophoton emission is metabolic activity, specifically 
oxidative processes (Cifra & Pospisil, 2014). This may be linked to the activity in the plasma 
membrane (Dotta et al., 2011). In diseased states, regular metabolic activity is often altered, 
typically increased compared to normal. This includes cancerous tissues and inflammatory 
responses. It has been demonstrated that increased metabolic activity in cell cultures led to 
significant increases in biophoton emission (Takeda et al., 1998). Dotta et al. found a significant 
increase in spectral power between malignant B16-BL6 and non-malignant HEK cell cultures 
(2011).  
 Many studies concerning human biophoton emission look specifically at the hands, an area 
with high photon counts in comparison to other body regions (Van Wijk, 2005). Jung et al. 
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performed a year long study of human biophoton emission, with the left and right hands as the 
region of interest (2005). Cohen and Popp measured an individual over a 9-month period, but only 
focused on the hands and forehead (1997). In these studies, the PMT was positioned directly above 
the region of interest. This limits the generalization of the results to the rest of the body. The use 
of biophoton emission as a diagnostic tool would ostensibly require global measurement before 
localized methodology could be used. There has not been a large research effort directed at the 
measurement of whole body biophoton emission. The few studies that have been conducted do not 
focus on repeated measurements of the same individual. 
 Methodology has a noticeable impact on the collection of data, due to the low intensity and 
diffuse nature of biophoton emission. The majority of biophoton activity is absorbed by the body 
(Rahnama et al., 2011). This leaves only a small amount that can escape and be observed. It is 
estimated that the external biophoton emission is two orders of magnitude lower than endogenous 
activity (Rahnama et al., 2011). Conditions such as temperature and humidity can change daily, 
and others like the technical aspects of a PMT or the distance between the PMT and the subject 
vary between laboratories. This makes the comparison of data difficult at best. One factor that is 
not well understood is why there is a slow decay of photon counts at the onset of recording. This 
effect is reportedly related to exposure to artificial light sources outside of the measurement area. 
Termed “delayed luminescence”, this is thought to be a contamination of the photon activity, and 
that requires longer measurement periods to collect reliable and consistent photon counts (Van 
Wijk, 2005). Understanding this effect is essential for accurate comparisons of biophoton activity. 
 This experiment aimed to conduct a long-term, repeated measurement of two participants. 
Data obtained could then be used to identify trends or patterns within each participant, or be used 
to discriminate between them. Comparisons between human and baseline conditions may help in 
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the identification of a human biophoton “signature”. All of these aims can also be applied over 




 One hundred and thirty-eight biophoton measures from two healthy male participants, aged 
22 and 26, were taken over a period of 156 days from February 10, 2017, to July 15, 2017. 
Biophoton measurements were taken once every 24 period. 
 Each daily measurement was performed using the same measurement chamber. The 
measurement chamber is a large wooden box, with dimensions 1.7m in height, 1.27m in length, 
and 1.32m in width. The chamber is painted black to minimize the amount of external photon 
exposure from entering while the chamber is closed. Additionally, the entire outside surface is 
covered with black towels to minimize contamination from external emissions. Inside the chamber, 
a plastic chair is placed directly in the centre for a participant to sit on during measurement. Four 
photomultiplier tubes (PMTs) are placed within the chamber. There is a PMT on each of the walls 
of the chamber, excluding the wall with the door, designated F-PMT, B-PMT, H-PMT, and one 
placed on the ceiling, designated Z-PMT. F-PMT is placed on the front wall; B-PMT is placed on 
the back wall; H-PMT is placed on the side wall opposite the door of the chamber; Z-PMT is 
placed on the ceiling directly above the participant. The three PMTs on the walls of the chamber 
are all placed in the midpoint of the wall horizontally, and approximately 0.15m from the center 
of the chamber. 
 First, a baseline recording of the empty measurement chamber was taken. This 
measurement was 4 minutes in duration at a sampling rate of 50Hz. The measurement chamber 
was not opened prior to this recording. This provided a baseline recording each day. After the 
baseline recording, one of the participants would enter the measurement chamber. Once the 
chamber was closed, there was a one-minute delay before the measurement began. This was to 
allow the biophoton measurement to estimate and approach a consistent output. After this one-
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minute delay, a four-minute measurement was taken at a sampling rate of 50Hz. Once the 
measurement was completed, the participant would exit the chamber. The second participant 
would then enter the chamber, and the same process as described above was repeated. The order 
in which the two participants were measured was alternated each day. After both participants were 
measured, a fourth recording was taken. The process described above was repeated except that a 
white polystyrene foam box was used to substitute for the position of the participant. This 
measurement was taken to observe how the photon emission changes without a biological system 
inside the chamber. Other pertinent data, such as any odd patterns, time of recording, etc. were 
noted by the experimenters for each experimental day. 
 Once the measurements were completed, data was extracted using Microsoft Excel. The 
data from each PMT was then subjected to a spectral analysis with the software program IBM 
SPSS. Data was truncated into average spectral power bins with a width of 1Hz and 0.1Hz, for 
further statistical analysis. These bins were used in addition to the average photon count per 
second. Means and standard deviations were used for both of these variables. Standardized mean 
photon counts were calculated by computing the average mean photon count and standard 
deviation of the mean photon count from all experimental days, and computing z-scores based on 





 A total of 136 valid days of measurement were used in the analysis, after removing outliers 
and days where no recording took place.  
 A discriminant analysis was performed to differentiate between the post-measurement and 
participant conditions. Spectral frequency bins, as well as mean intensities and standard deviations 
were included as possible variables. The discriminant function was able to correctly identify 90.2% 
of all cases (Λ = .455, χ(4) = 319.273, p < .001). Four main factors loaded in this function, shown 
in Table 2-1 below. 
Table 2-1. The main factors that loaded onto the discriminant function, and their standardized canonical 
coefficients.  
Variable 
Standardized Canonical Discriminant Function 
Coefficient 
B-PMT mean intensity -1.687 
H-PMT mean intensity -0.176 
F-PMT standard deviation 1.033 
B-PMT standard deviation 1.334 
  





Figure 2-1. Comparison of the four variables that loaded on the discriminant function. The mean intensity of 
B-PMT has been included on a separate axis for scale. Error bars represent standard error of the mean, n = 
136. 
  
 There were no significant differences between the mean intensity of each PMT by 
participant (Front: F(1,272) = 0.678, p = .411; Back: F(1,272) = 0.330, p = .566; Zed: F(1,272) = 0.198, 



























Figure 2-2. Comparison of mean intensities of photon recordings for each PMT across participants. None of 
the PMTs were significantly different between participants (α = .05). Error bars represent standard error of the 
mean, n = 136. 
 
 A second discriminant analysis was performed to differentiate between participants. This 
analysis used the same variables as the first discriminant analysis. No function was able to 
discriminate between participants across all 136 cases. As a follow up, multiple discriminant 
analyses were performed on each month of recording. Only the first month of recording produced 
a significant discriminant function. This function was able to correctly identify 100% of all cases 
(Λ = .191, χ(6) = 54.595, p < .001). The variables that loaded onto this discriminant function are 






















Table 2-2. The main factors that loaded onto the participant discriminant function, and their standardized 
canonical coefficients. The delta frequency bin has a frequency width of 0-3Hz; the alpha frequency bin has a 
frequency width of 7-10Hz. 
Variable 
Standardized Canonical Discriminant Function 
Coefficient 
F-PMT standard deviation 1.984 
B-PMT standard deviation -1.315 
H-PMT standard deviation 1.020 
Delta spectral frequency bin -1.098 
Alpha spectral frequency bin -0.504 
B-PMT coefficient of variation 0.759 
 
 Figure 2-3 shows the scores of each participant and their discriminant score. 
 
Figure 2-3. Box plot of the participant discriminant results. Please note that there is no overlap between the 
minimum of Participant 1 and the maximum of Participant 2. 
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 In order to determine if the discriminant was spurious, a discriminant analysis was 
performed for each week of the experiment. The prediction accuracy was averaged for each month 
(every four weeks). If the analysis was unable to produce a discriminant function, an accuracy 
score of 0 was assigned to that week. The results of this procedure are shown in Figure 2-4.  
 
Figure 2-4. Accuracy of discriminant functions over time, for differentiation of participants. The accuracy of 
discriminant functions is highest in the first month of the experiment, after which the accuracy drops off 
sharply for the remainder. Error bars represent standard error of the mean, n=4. 
  
 The mean photon counts for each PMT by condition are shown in greater detail in Figure 
2-5 below. A one-way ANOVA revealed there was a significant effect between the three 
conditions (Pre-baseline, Human, Post-baseline) for each PMT (F-PMT: F(2, 541) = 200.357, p < 
.001, η2 = .426; B-PMT: F(2, 541) = 40.852, p < .001, η2 = .131; Z-PMT: F(2, 541) = 31.433, p < .001, 
η2 = .104; H-PMT: F(2, 541) = 60.686, p < .001, η2 = .183). Post-hoc tests using Tukey HSD revealed 
that each condition was significantly different from one another (α = .05), in each PMT. The post-
baseline condition had the highest mean photon counts, followed by the human condition; 


















condition was lower than the human condition. The pre-baseline condition had the lowest mean 
photon counts in all PMTs. The standardized mean photon counts for the participants were not 
significantly different from one another in any of the PMTs, so they were grouped together as the 
human condition. 
  
Figure 2-5. Comparison of the standardized mean photon counts per condition from each PMT. Mean photon 
counts were standardized within each PMT. The pre-baseline condition has the lowest photon counts in all 
PMTs. In H-PMT, the human condition was higher than the post-baseline condition, which was the opposite of 
the other three PMTs. Both participants were grouped together, as they were not significantly different from 






































 Mean photon counts are perhaps the easiest statistic to observe directly from PMT 
recordings. Given that four PMTs were used throughout the experiment, this leaves four mean 
counts to compare for each recording session. Direct comparisons are potentially possible for three 
of the four PMTs (F-PMT, B-PMT, Z-PMT), but as the H-PMT is a different model of PMT from 
the previous three, direct comparisons are not possible. The magnitude of the mean photon counts 
from the two models of PMTs used can differ by up to a power of 10. Thus, standardization within 
each PMT is essential if any comparisons are to be made.  
 Unfortunately, due to the nature of the experimental process, mean photon counts are still 
not an optimal variable for discrimination between human conditions. They may not even be a 
discriminating factor between human and baseline conditions. Mean photon counts are useful for 
differentiation between conditions where the experimental chamber was exposed to outside light 
sources, or if the experimental chamber remained closed. The methods used for this study involved 
the recording of one “pre-baseline” measurement and one “post-baseline” measurement per 
recording session; this was done to observe if there was a noticeable difference in the mean photon 
counts from simply allowing outside light to enter the chamber.  This phenomenon is known as 
delayed luminescence, and has been described previously (Popp & Yan, 2002). 
 Light contamination seems to have the largest effect on mean photon counts at the start of 
the recording. As this light contamination dissipates and the dark condition of the experimental 
chamber returns to normal levels, the photon count decreases. An example of this can be seen in 
Figure 2-1. This gradual decrease was not observed in the pre-measurement baseline condition 
where the experimental chamber was not opened before recording. Due to light contamination, the 
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mean photon counts were significantly higher in the post-measurement baseline condition were 
the experimental chamber was opened compared to if the chamber was not opened. 
 A discriminant analysis could not successfully compute a model to differentiate between 
human and baseline conditions. Variables for this analysis included mean photon counts, spectral 
scores, and variance statistics including the standard deviation of photon counts and the coefficient 
of variation of photon counts. If the pre-measurement baseline condition (with no light 
contamination) was excluded from the analysis, the discriminant analysis was able to differentiate 
between human and post-measurement baseline conditions with a 90% classification accuracy. If 
light contamination is present in the collection of data, it seems that its inclusion or exclusion is 
enough to impact findings. Popp and Yan have previously shown that a hyperbolic equation can 
be used to mimic the decay of photon counts, and that there are differences in these oscillations 
between healthy and cancerous tissue (2002). Those findings relate to plant tissue and may not be 
relevant for other biological systems. 
 Mean photon counts and light contamination are important for discrimination between 
human and baseline conditions. For discrimination between human participants, mean photon 
counts are less important. Figure 2-2 shows a comparison of mean photon counts between 
participants. There were no significant differences in the mean photon counts between participants. 
 Mean photon counts are not the only data that can be obtained from PMT recordings. A 
spectral analysis can also be performed to discover trends within the data. A spectral analysis 
allows for the observation of repetitive cycles, or frequencies, that may not be evident in the 
intensity measures. With respect to photon measurements, a spectral analysis would convey 
information about the patterns in the photons that interact with the PMT, if any. For example, this 
analysis could indicate if there was a 20Hz pattern present, or if about one photon was reliably 
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emitted every 0.5ms. This may be related to the metabolic rate or some intrinsic property with 
respect to the tissue. 
 The discriminant analysis between participants revealed that were two variables derived 
from the spectral analyses of the recorded data. These variables showed that photons emitted 
within the delta frequency bin and the alpha frequency bin could distinguish participants. These 
bins represent frequencies of 0-3Hz and 7-10Hz, respectively. The frequency bins are calculated 
from the average of thousands of smaller frequencies obtained from the spectral analyses 
performed on each recording. Each measurement was composed of 12000 points; the spectral 
analysis leaves half of that, 6000 points. The largest frequency that can be measured by a spectral 
analysis is half of the sampling rate. In this experiment, the sampling rate was 50Hz; thus, the limit 
of the spectral analysis is 25Hz. This means that each point from the spectral analysis is 
representative of a frequency width of 4.17mHz (25Hz / 6000 points = 4.17 x 10-3 Hz/point). Thus, 
the 3Hz frequency bins are the average of 720 points.  
 The condensation of the frequency bins is not unique to this analysis, and has been 
previously performed with electroencephalograph results. This may help to justify the 
generalization of the results found in this experiment with other biophoton experiments. 
Discrimination analyses between living and non-living systems, and between living systems of 
different states (healthy vs. cancer), have been performed previously; however, little to no work 
has been performed to discriminate or identify differences between individuals or to determine if 
the same individual is consistent over time.  
 The inclusion of thousands of variables would not be an efficient way to evaluate possible 
differences between individuals in this novel branch of experimentation. Simplification of the data 
prior to analysis allows for more generalizable results within and between participants. While the 
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intricacies of the data may be lost this way, the thousands of variables will lead to spurious effects 
based on confounding problems related to multiple testing. Condensation of these variables allows 
for the main effects, if any, to remain observable while the efficacy of the statistical approach is 
maintained. 
 The interpretation of the frequency bins, in a biophoton experiment, is novel. The 
discriminant analysis that was able to differentiate between individuals for February 2017 only 
revealed two spectral variables that were significant: the delta (0-3Hz) frequency bin and the alpha 
(7-10Hz) frequency bin. It is beyond the scope of this experiment to determine what the specific 
biological origins of these frequency bins may be. Rather, general hypotheses will be examined. 
 Delta frequencies may be associated with the long-term metabolic activity of the 
participant. Biophoton emissions are a consequence of the metabolic processes associated with 
life. There exists a myriad of factors that influence what an individual’s specific metabolic rate 
may be at any given moment, but there must be a constant, slow supply of various molecules to 
ensure continued biological function. This underlying metabolic activity may be the source of the 
delta frequencies observed. Prasad and colleagues have discussed biophoton emission as possible 
mediator of intercellular communication (Prasad et al., 2014); therefore, these frequencies may 
also be related to intercellular communication. 
 Alpha frequencies may be associated with Schumann resonances. Schumann resonances 
are frequencies in the 7-8Hz range that are caused by the interaction between global lightning 
strikes in the ionosphere and Earth’s surface. The resonant frequencies can be shifted slightly by 
interactions with seismic energy, the height of the ionosphere, and the time of year. Schumann 
resonances have been correlated with electroencephalograph activity in humans (Saroka & 
Persinger, 2014). There may exist a correlation between Schumann resonance, brain activity, and 
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biophoton activity that could explain the source of the differences in the observed alpha frequency 
bin. 
 Though a successful discriminant function was found for the month of February, no 
significant functions were able to differentiate between participants for any of the other four 
months (March – June), or across the entire experiment. One potential explanation for this may be 
a spatial light pollution of the experimental chamber. Just as the introduction of outside light into 
the experimental chamber produced notable changes in recorded variables measured on each day 
over time, the repeated presence of the participants inside the chamber may have produced changes 
in the space of recording. 
 Some support for this claim is present from the data collected from the mean photon counts 
across each of the PMTs per condition. In the F-PMT, B-PMT, and Z-PMT, mean photon counts 
trend with the order of measurement, excluding the measurements of the human participants which 
were consistently similar. This means that the post-baseline condition had a higher mean photon 
count than the two human conditions, which seems contradictory to previous research. Crucially, 
this trend is not observed in the H-PMT. In the H-PMT recordings, post-baseline mean photon 
counts are higher than the pre-baseline, but not higher than the participants’ mean photon counts. 
The H-PMT recordings also seem to be the least sensitive to light contamination, as seen in the 
photon counts over time. 
 Similar to the way the participants biophoton signature contaminated the post-baseline 
measurement, they may have also contaminated the experimental space. This would lead to a 
homogenization of the environment within the experimental chamber as the participants continued 
to contaminate the light-sensitive environment. As this increase in contamination in the 
participants contributed to background processes and interfered, interfaced, or overlapped with the 
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biophoton output measured from the experimental space, they may have obscured the necessary 
information for discrimination. 
 Another possible explanation for the lack of significant discrimination may simply be due 
to the frequency bin sizes. The frequency bins used in the analysis were averages of 720 points. It 
is possible that these bins are simply too large and mask details that are required for the 
differentiation of individual participants. An increase in the sample size would be necessary for 
the inclusion of more variables. While 136 distinct days of measurement is a good start, more data 
is needed for that level of statistical testing. 
 This experiment was able to achieve some of its aims. Discrimination between human and 
baseline conditions was successful. Special care must be taken when working with light 
contamination. Discrimination between human participants was partially successful in one month 
of the experiment. A possible explanation for this inconsistency was the spatial contamination of 
the experimental chamber. Individual differences in slow rhythm metabolism may be a factor in 
the significance of the delta frequency band that allowed for the differentiation of the two 
participants. 
 The data that was measured by this experiment will be useful for future discrimination 
experiments. Taking proper and regular baselines is essential for successful interpretation. Spectral 
analyses can focus on the delta (0-3Hz) and alpha (7-10Hz) frequency ranges. Environmental 
factors, including humidity and temperature, must also be considered. Diagnostic information 
requires a healthy baseline for comparison. Ensuring accurate readings is paramount for the use of 
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IMPACT OF NON-ORGANIC MATERIAL ON BIOPHOTON 
EMISSION FROM B16-BL6 AND C2C12 CELL LINES: 
DISCRIMINATION BETWEEN HEALTHY 





 Metabolic activity is correlated with biophoton emission. Cancerous and non-cancerous 
cell types express different rates of metabolic activity. This allows for the potential discrimination 
of these cell lines based on their biophoton emission. “Healthy” non-cancerous and cancerous cell 
lines were allowed to grow and approximately 106 cultured cells and were placed within a nutrient 
agar moulds of different volumes. The biophoton activity of these cultures were measured for one 
minute at a 50Hz sampling rate. No significant differences were found as a function of agar mould 
volume. B16-BL6 cell cultures had significantly higher mean photon counts than controls, and 
produced different spectral power densities in multiple frequency ranges. B16-BL6 cell cultures 
and C2C12 cell cultures had significantly different spectral power densities in the 19.50Hz to 





 Ultraweak photon radiation from a biological source, or biophoton emission, has been 
measured in cultures of animal and plant tissue. The origin of this energy has been proposed to 
originate from metabolic reactions within the cell. The oxidation of free radicals acts as one of the 
primary sources of biophoton emission (Dotta et al., 2011). As such, changes in metabolic activity 
should alter some quality of biophoton emission. This has been demonstrated via temperature 
dependence on other metabolic reactions such as glycolysis (Popp, 2009). Differences in 
metabolism as a function of cell type may also be observable. 
 A potential application of the ability to differentiate between cell type would be to develop 
a diagnostic test for cancerous cells. Biophoton emission presents a non-invasive measurement of 
internal biological activity. Takeda et al. were able to demonstrate that the biophoton output of 
cancer cells was dependent on the size of the colony (1998). Later work performed by the same 
researchers was able to create images of tumors transplanted into mice with only biophoton 
emissions (Takeda et al., 2004). 
 One issue is the potential interference of surrounding non-malignant biological tissue. 
Characteristic activity of specific cell types will be necessary to accurately detect diseased tissue 
in an animal. In addition, the amount of biological tissue that may interfere can vary; for example, 
an epidermal melanoma would have a much lower amount of tissue within and around it compared 
to a breast cancer lipoma. Cancer growth has been described as an emergent phenomenon of the 
cell population (Popp, 2009). Understanding the potential interference that is a consequence of 
surrounding tissue may allow for increased detection. 
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 To that end, the biophoton emission of cell cultures, including human and murine cell lines, 
were observed. The effect of an inert mass around each cell culture was modified by the placement 
of the cells within a nutrient agar mould of different volumes; greater volume of agar corresponds 
to a greater tissue depth. The aims of this experiment were to determine the impact of this artificial 
depth on the characteristics of biophoton emission, if any, and to differentiate between the 





 Various cell lines including HSG (human submandibular gland cells), AsPC (human 
pancreatic cancer cells), MCF-7 (human breast cancer cells), B16-BL6 (murine malignant 
melanoma cells), C2C12 (murine muscle cells), NIH (murine mesenchymal cells), and 4T1 
(murine breast cancer cells), were cultured in DMEM containing 10% fetal bovine serum and 1% 
antibiotics (Hyclone). Cells were separated using trypsin, counted, and 106 cells were suspended 
in 50µL Matrigel.  This culture suspension was then placed within one of three containers that held 
a volume of 1% nutrient agar dependent on the size of the container. These were termed small 
(~50mL volume), medium (~100mL volume) and large (~500mL volume). A channel was created 
in the agar so that the cell culture was placed in the centre of the container, regardless of the size. 
Controls were performed using each of the containers containing only agar. Biophoton 
measurements were obtained within 24h after the culture was placed within the agar container. 
The container was then measured for one minute at a sampling rate of 50Hz within the 
experimental chamber. Within the chamber, four individual photomultiplier tubes (PMTs) were 
used to record biophoton activity. Baseline recordings were also performed. These were done by 
opening the door of the experimental chamber as if a container had been placed inside and then 
performing a normal measurement. 
 After recording, the data was imported into IMB SPSS for standardization, and statistical 
and spectral analyses. Mean photon counts were standardized with respect to each PMT to allow 





 A one-way ANOVA was performed to compare the standardized mean photon counts of 
the seven cell conditions; B16-BL6, NIH3T3, HSG, MCF-7, 4T1, AsPC, and C2C12. No 
violations of homogeneity were found (W(8,109) = 1.123, p = .353). No significant effect was found 
between cell lines (F(8,109) = 1.787, p = .087). The mean photon counts are shown below in Figure 
3-1. 
 
Figure 3-1. Comparison of standardized mean photon counts as a function of cell line. The sample size of each 
condition was 33, 13, 4, 3, 5, 10, and 10, respectively. There were no significant differences as a function of cell 
line. Error bars represent standard error of the mean. 
  
 Due to low sample sizes, the majority of the results below use the B16-BL6 samples, as 
they were the cell line with the largest sample size of 33. 
 A one-way ANOVA was performed to compare the mean photon counts of the baseline, 
control, and B16-BL6 conditions. No violations of homogeneity were found (W(2,69) = 3.285, p = 

































HSD revealed the B16-BL6 condition was significantly higher than the control condition. Baseline 
conditions were not significantly different from either B16-BL6 or control conditions. This is 
shown in Figure 3-2 below. 
 
Figure 3-2. Comparison of the standardized mean photon counts between the baseline, control, and B16-BL6 
conditions. The sample size of each condition was 5, 34, and 33, respectively. Control and B16-BL6 conditions 
were significantly different from each other; the baseline condition was not significantly different from either. 
Error bars represent standard error of the mean. 
  
 Mean photon counts were compared as a function of sample size, including the control 
condition. This included all cell lines. A one-way ANOVA revealed a significant main effect 
((F(3,146) = 4.079, p = .008, η2 = .078); post-hoc Tukey’s HSD revealed that the small, medium and 
large container conditions were significantly higher than the control conditions, but not 



































Figure 3-3. Comparison of standardized mean photon counts as a function of container size. The sample size of 
each condition was 34, 54, 40, and 22, respectively. All size conditions were significantly higher than the control 
condition, but not significantly different from each other. Error bars represent standard error of the mean. 
  
 Comparisons of spectral power density were also performed between control conditions 
and small, medium, and large container sizes. For this only B16-BL6 samples were used, since 
different cell lines have been shown to generate different spectral power densities. Homogeneity 
of variance was violated for all spectral power density comparisons as shown by Levene’s test (p 
< .05); the Kruskal-Wallis test was used as a non-parametric substitute for the following 
procedures as noted. 
 The first frequency bin that was compared was the low frequency bin (0-0.9Hz). There was 
a significant difference between the four conditions (χ2(3) = 15.074, p = .002, η2 = .203); post-hoc 
homogenous subsets revealed that the control condition was significantly different from the B16-
BL6 samples of all container sizes. There were no differences between the different sizes of 


































Figure 3-4. Comparison of the spectral power density from the low frequency bin (0-0.9Hz) between B16 
container sizes and control samples. Sample size for each group is 34, 19, 9, and 6, respectively. The small, 
medium, and large spectral power density was significantly greater than the control condition; they were not 
significantly different from each other. Error bars represent standard error of the mean. 
  
 The above procedure was repeated for the remaining frequency bins: delta (1.0 – 4.9Hz), 
theta (5.0 – 8.9Hz), alpha (9.0 – 12.9Hz), low beta (13.0 – 16.9Hz), mid beta (17.0 – 20.9Hz) and 
high beta (21.0 – 25.0Hz). The relevant statistics are shown in Table 3-1 below. 
Table 3-1. Comparison of the Kruskal-Wallis tests comparing spectral power density between container sizes, 
per frequency bin. The degrees of freedom for all tests was 3. 
Frequency bin Test statistic (χ) Probability (p) Effect size (η2) 
Delta 14.366 .002 .422 
Theta 20.227 < .001 .507 
Alpha 20.012 < .001 .504 
Beta, low 13.785 .003 .412 
Beta, mid 22.107 < .001 .529 

























 The post-hoc tests for each Kruskal-Wallis analysis were consistent; the control condition 
was always significantly different from the small, medium, and large container sizes, and the cell 
container sizes were not significantly different from each other. The key difference between the 
spectral power density of the low frequency bin and the six other frequency bins was that the trend 
reversed. In the low frequency bin, the cell conditions had a greater spectral power density than 
the control condition while the opposite was true for the other six frequency bins. As an example, 
the mid beta frequency bin is shown below in Figure 3-5. 
 
Figure 3-5. Comparison of the spectral power density from the mid beta frequency bin (17.0 - 20.9Hz) between 
B16-BL6 container sizes and control samples. Sample size for each group is 34, 19, 9, and 6, respectively. The 
small, medium, and large spectral power density was significantly lower than the control condition; they were 
not significantly different from each other. Error bars represent standard error of the mean. 
 
 Next, the spectral power density of the control condition and the B16-BL6 condition was 
compared with the baseline condition. B16-BL6 cell samples were grouped together, regardless of 
























tests were used to compare means across frequency bins. The results from these tests are shown in 
Table 3-2 below. 
Table 3-2. Comparison of the Kruskal-Wallis tests comparing spectral power density between baseline, 
control, and B16-BL6 conditions, per frequency bin. Degrees of freedom for all tests was 2. 
Frequency bin Test statistic (χ) Probability (p) Effect size (η2) 
Low frequency 17.155 < .001 .342 
Delta 16.300 < .001 .331 
Theta 20.705 < .001 .386 
Alpha 22.013 < .001 .400 
Beta, low 12.177 .002 .270 
Beta, mid 21.918 < .001 .399 
Beta, high 21.090 < .001 .390 
 
 Post-hoc tests revealed that the baseline condition was not significantly different from the 
control condition in all frequency bins. The baseline condition was significantly different from the 
B16-BL6 condition, with the exception of the low beta frequency bin. In this bin, the cell and 
control conditions were still significantly different. The trends were dependent on the frequency 
bin, similar to Figure 3-4 and Figure 3-5. Figure 3-6A shows the spectral power density in the low 




Figure 3-6. Comparison of the spectral power density between conditions, in the low frequency bin (upper) and 
the alpha frequency bin (lower). The sample size for each condition was 5, 34, and 33, respectively. The cell 
condition was significantly different than the baseline and control conditions; higher in the low frequency bin, 
and lower in the other six frequency bins. Error bars represent standard error of the mean. 
  
 Comparisons were made between the spectral power density of the B16-BL6 cell line with 
all non-cancerous cell lines, which included HSG (human submandibular gland), NIH3T3 (murine 
































































significant results following spectral power density analysis when compared to the B16-BL6 cell 
conditions and the control condition. The frequency bin which produced the largest effect size was 
the mid-beta frequency bin, shown in Figure 3-7. A Kruskal-Wallis ANOVA revealed a significant 
difference between the two cell conditions and controls (χ(2) = 30.094, p < .001, η2 = .477); post-
hoc tests revealed a significant difference between all conditions. 
 
Figure 3-7. Comparison of the spectral power density of the mid-beta frequency bin between control, B16-BL6, 
and control conditions. The group sizes for each are 34, 33, and 10, respectively. All three conditions were 
significantly different from each other. Error bars represent standard error of the mean. 
 
 To further explore this effect, the mid-beta frequency bin was divided into eight 0.5Hz 
frequency bins (17.00 – 17.49Hz, 17.50 – 17.99Hz… 20.50 – 20.99Hz). Mann-Whitney U tests 
were performed between the B16-BL6 and C1C12 conditions’ spectral power density. Only the 
19.50 – 19.99Hz frequency bin showed that the spectral power density of the B16-BL6 condition 
was significantly higher than the C2C12 condition (U(33,10) = 96.0, p = .047). This is shown in 

























Figure 3-8. Comparison of the spectral power density of the 19.50 – 19.99Hz frequency bin between B16-BL6 
and C2C12 conditions. Group sizes are 33 and 10, respectively. The B16-BL6 condition was significantly higher 



























 The majority of cell lines were not used in analysis due to low sample sizes.  The variability 
present within each case of the B16-BL6 conditions were considerable, even with a total sample 
size of 33. As seen in Figure 3-1, there is considerable variation in the conditions with low sample 
sizes. Minute deviations from the expected procedure due to technical issues, experimental error, 
etc., may have an impact on the quality of the measurements that can aversely affect the data. This 
has been noted as a common source of variance between laboratories, specifically when PMTs are 
involved (Van Wijk, 2005). 
 B16-BL6 is the main cell line that will be discussed here. This line had the most samples 
measured (33) out of all cell lines. The B16-BL6 cell line is also the closest line to match the 
sample size of the control condition (34), which for this experiment was a container with only 
nutrient agar. Five baseline measurements were also performed, which acted as a measurement of 
the empty experimental chamber.  
 A comparison of the mean photon counts between B16-BL6 samples and the non-cell 
conditions (control and baseline) was performed first, shown in Figure 3-2. As expected, the B16-
BL6 samples had significantly higher mean photon counts when compared to controls. This is 
similar to previous results with B16-BL6 cells and control samples (Dotta et al., 2011). 
Unexpectedly, the baseline condition was not significantly different from either controls or the cell 
samples. This lack of statistical significance is most likely due to differences in group sizes, 
approximately 30 measurements each for B16-BL6 samples and controls, but only 5 baseline 
measurements were performed. An increase in baseline measurements to match the other groups 
would decrease the variability and most likely be significantly lower than the cell samples, similar 
to the control. Whether the agar alone is significantly different from the baseline is uncertain.  
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 Next, a comparison of mean photon counts between different container volumes was 
performed. There were no significant differences between control (agar-only) containers of 
different volumes. Thus, they were grouped together to compare different container volumes 
containing the B16-BL6 cell samples. 
 The three container volumes used (small, medium, and large) showed significantly higher 
mean photon counts than control samples, but they were not significantly different from each other. 
The number of cells within each sample was approximately 106, regardless of the container (and 
agar) volume. The volume of agar had no effect on the number of photons that reached the PMT. 
 In this experiment, the role of the agar was to mimic non-cancerous tissue. Thus, a greater 
agar volume would be indicative of greater tissue depth. If biophoton emission is to be used as a 
diagnostic tool, the ability to measure malignant tissue at different depths would be required. The 
data shown here supports the idea that the mean photon counts detected from a biological sample 
do not change significantly as a function of agar depth. 
 The results of Figures 3-4 and 3-5 show that the spectral characteristics of the B16-BL6 
samples are also unaffected by agar volume. This was true for all of the frequency bins used: 0-
0.9Hz, 1.0-4.9Hz, 5.0-8.9Hz, 9.0-12.9Hz, 13-16.9Hz, 17-20.9Hz, and 21.0-25.0Hz. The frequency 
ranges of these bins were modelled after typical EEG frequency bins: delta, theta, alpha, and beta. 
All of the bin sizes were equal, with the exception of the 0-0.9Hz, or “low frequency” bin. The 
agar depth’s lack of impact on the spectral characteristics of the B16-BL6 samples is more support 
for the ability of biophoton emission to be detected through tissue. These frequencies could be 
reflective of metabolic processes within the cell (Karbowski 2016). 
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 The spectral densities in the B16-BL6 samples were the inverse of the control samples. For 
the low frequency bin, the B16-BL6 samples had a greater level of photons than controls; for all 
other frequency bins, the B16-BL6 samples had a lower level of photon emission than controls. 
This suggests that there is something unique about the cell samples that is not simply due to the 
surrounding agar. 
 Finally, comparisons were made between the B16-BL6 samples and non-cancerous cell 
lines, or “healthy” cell lines. From all the healthy cell lines tested, only C2C12 cell samples had 
significantly different spectral densities. These two cell lines are both derived from the same 
species, Mus muscularis, commonly known as the house mouse. This eliminates the issue of 
species differences, which may have been an issue as cell lines from different species were 
measured as well. 
 The statistical difference between the C2C12 condition and the control condition may have 
been driven by a smaller frequency range. The mean spectral power densities shown in Figures 3-
4 through 3-7 were calculated as an average of 240 real data points from the spectral analysis for 
each case. To accurately inspect within mid-beta frequency bin, mean spectral power densities 
were calculated from only 30 real data points. This produced eight frequency bins with a width of 
approximately 0.5Hz. Of these 0.5Hz frequency bins, only the 19.50 – 19.99Hz frequency bin 
showed a significant difference between B16-BL6 cells and C2C12 cells. A Kruskal-Wallis 
ANOVA was not used, as it had been demonstrated that there was a significant difference between 
the B16-BL6 cells and the control condition in higher frequency bins, and that the spectral power 
density of the C2C12 cell samples tended to be lower than the B16-BL6 cell samples. 
 It is important to note that there was no statistical difference between the mean photon 
counts of the B16-BL6 and C2C12 conditions. As the spectral power density data shows, the 
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measurable differences between the mentioned conditions will not be the number of biophotons 
released but the frequency patterns that described how they are released. One of the key differences 
between the two cell lines is their metabolic activity. B16-BL6 cells are cancerous; they will 
continue to grow and divide until they reach confluence and die. C2C12 cells also divide quite 
rapidly; however, as the culture approaches confluence the cells will begin to differentiate into 
myotubules and cease proliferation. Popp has suggested that the number of individuals within a 
population can lead to constructive and destructive interference patterns (2003). This could lead 
to variable biophoton emission at different stages of growth. 
 The B16-BL6 and C2C12 cell lines have different metabolic behaviour. Kim et al. have 
shown that there is a positive relationship between the biophoton emission and the proliferative 
rate of the HeLa cancer cell line (2007). Metabolism is one of the proposed mechanisms to explain 
the production of biophoton emission. It is intuitive that metabolic differences would then correlate 
with changes in biophoton emission frequency. Any factor that could affect metabolism could also 
affect biophoton emission, such as the number of mitochondria (Rahnama et al., 2011). An 
accurate description of these changes in metabolic activity would require a vast amount of data. 
These changes in biophoton activity would appear to be very subtle as only two of the observed 
cell lines were statistically different, with regard to spectral power density. 
 Differentiation of cancerous and healthy cells with the use of biophoton activity will not 
be a simple task. Measurements must be consistent and accurate. True discrimination will require 
large database-levels of information. Spectral analyses, or some other measure of frequency, will 
be essential as a supplement to mean photon counts. Murugan et al. were able to discriminate 
between cancerous and non-cancerous cell lines with the use of specific wavelength filters (2018). 
Further research will also have to examine combinations of cell lines or tissue types. 
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Discrimination in an in-vivo setting will also have to account for the combination of tissue types, 
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EXPOSURE OF B16-BL6 CELL CULTURES TO EXTREMELY 
LOW-FREQUENCY ELECTROMAGNETIC FIELD ALTERS 




 Biophoton emission is produced by all living systems; this emission pattern has been shown 
to be altered by the presence of an electromagnetic field (EMF). Cultures of B16-BL6 cells were 
exposed to a weak EMF produced by a specially constructed EM generator, called the ‘Resonator’, 
for one hour. This EM generator incorporates multiple geometric ratios in its design, including the 
golden ratio (phi), pi, root 2, root 3, and root 5, and has been used to purify water of toxins. There 
was a significant decrease in mean photon counts from B16-BL6 cells exposed at a distance of 1m 
compared to those exposed at 0m. Alterations in the spectral power density variability were also 
observed in the 8-10Hz range. The EM generator may have an impact on the viability of the 





 All living biological systems emit low levels of electromagnetic radiation, referred to as 
biophoton emission. It has been proposed that metabolic activity is the primary source of biophoton 
emission, specifically the oxidation of free radicals. This is supported by experimental evidence 
including the addition of hydrogen peroxides to tissue, or a reduction of tissue antioxidants 
(Alipour, 2015). This proposed mechanism is the same for both types of biophoton emission: 
spontaneous and induced. Spontaneous biophoton emission is produced by the natural metabolic 
activity of the organism. Induced biophoton emission is observed after an organism has been 
exposed to one or more of several factors, which can be natural or artificial. These factors include 
bacterial or viral infection, stress, external temperature, and ionizing radiation, to name a few 
(Cifra & Pospisil, 2014). Electromagnetic fields (EMFs) have also been previously demonstrated 
to induce biophoton emission in combination with specific wavelengths of light (Karbowski et al. 
2016).  
 The examination of the effect of exposure to an EMF alone on biophoton emission has not 
been done. In the experiment by Karbowski and colleagues, three complex, time-varying EMF 
patterns were used (2016). The central effect observed was the increase in mean photon counts 
when B16-BL6 cells were exposed to a combination of both an EMF and 450nm light. In this 
experiment, the aim was to focus on the characteristics of a single EMF.  
 The EMF used in this experiment, was generated by a novel device invented by Dr. K. 
Shallcross. This EM generator, referred to as the ‘Resonator’, uses a series of metallic roller 
magnets arranged at specific angles to create a pattern derived from a sacred geometry. Sacred 
geometry refers to numerical values derived from simple geometric relations, such as π, √2, √5, 
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and φ (Shallcross, 2016). When the device is on, the roller assemblies rotate, which generates a 
weak EMF, in the range of 1µT to 10µT. When the device is off, no EMF is generated. 
 Previous experiments with the ‘Resonator’ have shown differential effects on the growth 
rate of bacterial cultures (Tessaro et al., 2015a). Three of the examined bacteria species were 
shown to have an increased growth rate after exposure, while one species had a decreased growth 
rate. This suggests that the complexity of the ‘Resonator’ field is such that it can have opposite 
effects on different species. This is most likely mediated via different effects on cellular metabolic 
pathways. 
 In addition, exposure of the ‘Resonator’ EMF to B16-BL6 cells for three hours has been 
shown to significantly decrease cell viability (Tessaro et al., 2015b). Takeda and colleagues have 
demonstrated that biophoton emission in cancerous cells was related to the population size (Takeda 
et al., 1998). Thus, if exposure to the ‘Resonator’ EMF is correlated with decreased cell viability, 
and biophoton emission is correlated with cell population, there should be an observable decrease 





B16-BL6 cell cultures were grown in DMEM supplemented with 10% fetal bovine serum 
and 1% antibiotics on 10mm Petri dishes and allowed to reach confluence in a water-jacket copper-
lined incubator at 37°C (95% air, 5% CO2). Cell cultures were grown on Petri dishes in groups of 
16. Once confluent, the plates were removed from the incubator and placed into one of four 
conditions: Field 1m, Field 0m, Sham 1m, Sham 0m. Each condition contained four cell plates. 
These conditions refer to the state of the ‘Resonator’, either with an active magnetic field in the 
Field conditions, or with the device turned on but with no movement of the coils; these were the 
Sham conditions. The cell plates were placed on a table at either 1m or 0m from the ‘Resonator’. 
Vertically, the cell plates were separated from the ‘Resonator’ by a distance of approximately 10-
15cm. The distance of vertical separation was constant between the 1m and 0m conditions. The 
plates were arranged side by side, such that they formed an approximate square on the surface of 
the table. This table did not make physical contact with the ‘Resonator’ to remove any vibrational 
effects from the spinning of the ‘Resonator’ coils. The ‘Resonator’ was then turned on for the Field 
conditions. Cell plates were left on the table for no less than one hour. 
Once the exposure was complete, the biophoton output of the cell plates was immediately 
measured. This measurement was performed in the experimental chamber, a specially constructed 
space measuring 1.32m long, 1.27m wide, and 1.70m in height. Before the experimental chamber 
was opened, a baseline measurement was taken. The cell plate was placed on a small polystyrene 
box, which is located on a chair in the centre of the experimental chamber. The sample was 
measured with four PMTs, which were located on three walls and the ceiling of the experimental 
chamber. Each PMT was separated from the sample by a distance of 15cm. A one-minute delay 
between the closure of the experimental chamber and the start of the measurement ensured minimal 
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light contamination of the cell plate measurement. Each cell plate was measured for two minutes. 
Including the one-minute delay, each plate was in the experimental chamber for three minutes. 
After each plate had been measured, a post baseline measurement was performed. This procedure 
was identical to the cell plate measurement, including the one-minute delay. Field and sham 
measurements for plates exposed at any given distance were recorded on the same day to minimize 
daily variations. 






 All of the analyses below were performed with the data from the PMT located at the Head 
position. Only the second minute of the measurement was used for analyses. A total of 14 cases 
from two different days were removed due to outlier effects. This gave a total N of 41. 
First, a comparison was made between the baseline condition and all cell conditions. A 
Student’s t test for independent samples revealed a significant difference between the baseline and 
the cell conditions (t = -6.260, p < .001, η2 = .445). The cell condition had significantly higher 
mean photon counts than the baseline condition. This is shown in Figure 4-1. 
 
Figure 4-1. Comparison of the mean photon counts between the baseline condition and all B16-BL6 conditions. 
The B16-BL6 condition was significantly higher than the baseline condition. Error bars represent standard 
error of the mean; n = 5 for baseline, n = 36 for B16-BL6. 
To expand on the B16-BL6 conditions, a pair of Student’s t tests for independent samples 
were used to compare mean photon counts between field condition and distance. This is shown in 
Figure 4-2 below. There was no significant difference in mean photon counts between the Sham 
























Field 1m condition were significantly lower than the Field 0m condition (t(18) = 2.120, p = .048, η2 
= .200). 
 
Figure 4-2. Comparison of the mean photon counts between Sham and Field conditions at 0m and 1m. There 
was no significant difference between the Sham 0m and Sham 1m conditions; the Field 1m condition was 
significantly lower than the Field 0m condition. Error bars represent standard error of the mean; the n for 
each condition was 8, 8, 12, and 8, respectively. 
  
A series of one-way ANOVAs were performed to compare the spectral power density 
variability by condition membership. The spectral power density variability is the standard 
deviation of the spectral power density, per case. For this procedure, the spectral power density 
variability was averaged into multiple frequency bins, each with a width of 1-4Hz. The only bin 
that produced a significant main effect was the low alpha (8-10Hz) frequency bin (F(3,32) = 4.047, 
p = .015, η2 = .255). Post-hoc tests revealed the effect was being driven by the difference between 


























Figure 4-3. Comparison of the spectral power density variability in the low alpha frequency bin. There was a 
significant difference between the four conditions; post-hoc tests revealed the significance was being driven by 
the Sham 1m and Field 1m conditions. The Field 1m condition spectral power density variability was 
significantly higher than the Sham 1m condition. Both Sham and Field 0m conditions were not significantly 
different from any other conditions. Error bars represent standard error of the mean; the n for each condition 





































 The mean photon counts from B16-BL6 cell cultures were significantly higher than the 
baseline, regardless of experimental conditions. It is evident that the presence of a biological 
system increases the mean photon count as measured by the PMT. This is consistent with previous 
findings.  
 A comparison of mean photon counts between the experimental conditions revealed novel 
results. The sham conditions were not significantly different from one another, which would be 
expected. The proximity to the static EMF produced by the ‘Resonator’, while inactive, did not 
seem to impact the mean photon counts. 
The field conditions exhibit distance effects. The Field 1m condition had significantly 
lower mean photon counts compared to the Field 0m condition. There are three possible 
interpretations: one, the induced EMF from the ‘Resonator’ at 0m led to increased mean photon 
counts in the Field 0m condition; two, the induced EMF from the ‘Resonator’ at 1m led to 
decreased mean photon counts in the Field 1m condition; three, a combination of effects one and 
two. Another factor to be considered is the impact of vibrational effects. Vibrational effects have 
been implicated in a possible mechanism of ‘Resonator’-cell interaction (Tessaro, 2015b). Thus, 
vibrational effects may interpose themselves with the EMF effects while the ‘Resonator’ is active; 
however, the plates were not placed in direct contact with the ‘Resonator’ to minimize the effects 
of vibration. 
 The spectral power density of the four conditions were compared with a series of one-way 
ANOVAs; no significant differences were found. The variability of the spectral power density was 
also compared in a similar fashion; a significant effect was found in the low alpha frequency bin. 
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This frequency bin was an average of the spectral power density variability scores in the 8-10Hz 
frequency range. Post-hoc Tukey HSD revealed that the effect was driven by the Sham 1m and 
Field 1m conditions. The spectral power density variability was significantly higher in the Field 
1m condition compared to the Sham 1m condition. 
 The implications of these two effects, mean photon counts and spectral power density 
variability, are centred on the Field 1m condition. This condition had significantly lower mean 
photon counts than the Field 0m condition, and significantly higher spectral power density 
variability than the Sham 1m condition. This implies fewer photons are being released and the 
rhythmicity of photon emission in the 8-10Hz range is less consistent. If the B16-BL6 cells’ 
metabolic activity is altered by the generated EMF, this may explain why the counts were lowered 
in the Field 1m condition. The EMF that is generated is an extremely low-frequency field which 
does not change as a function of position (relative to the ‘Resonator’), although the intensity 
decreases with distance. This is a significant quality, since the signal pattern and frequency remain 
consistent over distance, the only EMF factor that would change between the Field 0m and Field 
1m conditions is the intensity of the field.  
 It is important to mention that the spectral power density variability of the Sham conditions 
were not significantly different from the spectral power density variability of the Field conditions. 
This may be a function of low sample size. High variability is also a common issue when biophoton 
emission is involved. This is often why spectral analyses are performed. The cell cultures were 
removed from the incubator for exposure and for measurement. Ideally, both of these processes 
should be carried out in a temperature-controlled environment.  
 This experiment was meant to act as a brief observation of the biophoton emission patterns 
produced by the B16-BL6 cell cultures. As such, no cellular observations were made. Future 
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experiments should include cell counts and viability. Comparisons could then be made directly 
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The results of the previous experiments have all demonstrated that unique biophoton 
emission is associated with biological systems. The presence of a biological system, including a 
human or a cell culture, is enough to produce significant changes in measured photon activity. 
Mean photon counts were the most apparent difference between biological and baseline samples. 
This is reflective of the overall intensity of the measured subject; more measured photons, more 
released photons, more light, higher intensity.  
 The appearance of intensity effects is not novel for living systems. Even as early as 1975, 
inanimate objects were shown not to increase photon counts (Van Wijk, 2005). There is something 
unique about biological systems that produces an increase in mean photon counts. The most 
probable source of this increased photon activity is metabolism. Specifically, biophoton emission 
is thought to be associated with the oxidation of electronically exited species (Cifra, 2014). 
Increases in metabolic activity should lead to increases in biophoton emission. 
 While that may be true in theory, in practice it is difficult to observe. As seen in Chapter 
3, no intensity differences were observed between B16-BL6 and C2C12 cell lines. While both cell 
lines are metabolically active, intensity alone was not able to differentiate between the two. The 
two human individuals in Chapter 2 also did not present statistically different intensities of photon 
emission. This does not indicate that metabolic activity has no impact on intensity, but rather that 
the metabolism of the organisms compared must be substantially different in order for differences 
to be measurable. Metabolism does not appear act as a method of differentiation on its own. 
 Information must be gleaned from other areas. The previous experiments show that it is 
the pattern of photon activity, rather than mean photon counts, that are able to account for the 
differences between organisms. Significant spectral power density differences were present in all 
three experiments. Spectral power density is reflective of the underlying patterns present within a 
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time-series. These patterns may or may not be apparent on visual inspection of the data, or may 
require Fourier transformation to be detected. 
 Difficulty comes in the interpretation of the spectral power density. The observable 
frequencies are restricted by the Nyquist limit, effectively half the sampling rate of the 
measurement device. The PMTs used in this experiment were set to their maximum sampling rate, 
50Hz; thus, the highest observable frequency from spectral analysis was only 25Hz. Ideally, the 
use of a PMT with a higher sampling rate would be able to provide higher frequencies that was 
not detectable in this experimental set-up. 
 Another important distinction to make is that the frequencies in question are not indicative 
of the frequency of the photons that interact with the PMT; rather, they represent the rhythm by 
which photons interact with the PMT. A significant frequency band in the 8-10Hz range indicates 
that photons interact with the PMT 8-10 times per second, not that the photon itself has an 8-10Hz 
frequency. Thus, these frequencies are more indicative of biological rhythms like those associated 
with metabolism. These patterns may be related to intercellular communication. Research by Dotta 
and colleagues has shown that the introduction of epidermal growth factor in B16-BL6 cell 
cultures increased the biophoton emission energy intensity (2011). Photons can degrade 
cryptochrome, a protein involved with maintaining the calcium-calmodulin complex that regulates 
cell division (Alipour 2015). 
 Different frequency bins of photon emission were revealed as significant in each 
experiment. In Chapter 2, these bins were in the alpha (7-10Hz) and delta (0-3Hz) range; in Chapter 
3, it was the 19.50 -19.99Hz bin; in Chapter 4 the significant bins were again in the alpha range. It 
was unlikely that one frequency bin would be found that would be able to explain all of the 
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differences between species or individuals. There exists an incredible amount of diversity within 
and between individuals; diversity would be expected in these observed frequency bins as well. 
 One important result that was consistent across experiments was that the changes in the 
frequency of the released photons between organisms/individuals are significantly different 
without an increase in mean photon counts. With metabolism as the primary source of biophoton 
emission, this would indicate that the total amount of energy within an individual is conserved; the 
difference is related to how that energy is allocated to various functions that alters the frequency 
of the emitted photons. This would not be the case if the mean photon counts also increased 
between organisms, as that may account for frequency increases. 
 One issue that arose in the data analysis of the experiments was the presence of delayed 
luminescence. This effect is observed immediately following exposure to sources of artificial light, 
even at low intensities. To avoid this effect, the measurement of all experiments was delayed by 
one minute after the subject was placed within the experimental chamber. For Chapter 4, analysis 
was only conducted on the second minute of the recording, or three minutes after the subject was 
placed within the chamber. The second technique seems to be the most consistent technique in 
terms of the reliability of the mean photon counts. Future studies should aim to either: delay the 
measurement until reasonably consistent photon counts are achieved; or, segment the recording 
such that only the segments with consistent photon counts are analyzed. Methods such as those 
used by Popp and Yan to mathematically explain delayed luminescence could also be employed 
(2002). 
It was observed that the spectral results of photon emission divided into frequency bins had 
the most relevance to the discrimination of healthy and unhealthy tissues. The detection of 
biophoton emission is non-invasive and could be developed as a diagnostic tool. The largest 
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logistical challenges would include the set-up of PMTs and the required dark environment. If there 
is a biophoton activity that can be identified and associated with various cancers, then regular 
diagnostics and early detection of cancer could be achieved. The use of induced biophoton 
emission could also be used as a diagnostic if populations of cells respond to the same stimulus in 
the same fashion. Murugan and colleagues have demonstrated specific biophoton peaks released 
in response to the specific coordination of light and an EMF (2018). 
 These results showed that discrimination between organisms is possible with the use of 
only biophoton emission data. With enough research, biophoton emission may become a realistic 
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LIST OF ABBREVIATIONS 
4T1:  4T1, murine breast cancer 
AsPC: AsPC-1, human pancreatic cancer 
B16-BL6: B16-BL6-C57bl, murine melanoma 
C2C12: murine myocyte 
DMEM: Dulbecco’s Modified Essential Medium 
EMF:  electromagnetic field 
HSG:  human salivary gland 
MCF-7: human breast cancer 
NIH-3T3: mouse mesenchymal tissue 
PMT:  photomultiplier tube 
UPE:  ultra-weak photon emission 
